![](https://newsheater.com/wp-content/uploads/2020/01/Image-149.png)
Novo Nordisk ADR (NVO) Shares Down Despite Recent Market Volatility
Novo Nordisk ADR (NYSE: NVO)’s stock price has plunge by -1.13relation to previous closing price of 136.26. Nevertheless, the company has seen a -0.34% plunge
Novo Nordisk ADR (NYSE: NVO)’s stock price has plunge by -1.13relation to previous closing price of 136.26. Nevertheless, the company has seen a -0.34% plunge
The price-to-earnings ratio for Novo Nordisk ADR (NYSE: NVO) is above average at 46.47x. The 36-month beta value for NVO is also noteworthy at 0.43.
Novo Nordisk ADR (NYSE: NVO) has a higher price-to-earnings ratio of 46.43x compared to its average ratio. NVO has 36-month beta value of 0.43. Analysts
Novo Nordisk ADR (NYSE: NVO) has a higher price-to-earnings ratio of 44.58x compared to its average ratio. NVO has 36-month beta value of 0.43. Analysts
The stock of Novo Nordisk ADR (NVO) has seen a 4.54% increase in the past week, with a -4.66% drop in the past month, and
The price-to-earnings ratio for Novo Nordisk ADR (NYSE: NVO) is above average at 43.31x. The 36-month beta value for NVO is also noteworthy at 0.44.
Novo Nordisk ADR (NYSE: NVO)’s stock price has plunge by 0.97relation to previous closing price of 126.73. Nevertheless, the company has seen a -3.92% plunge
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.